Please provide your email address to receive an email when new articles are posted on . The expanded indication for BP-lowering treatment by the 2021 Kidney Disease: Improving Global Outcomes ...

Please provide your email address to receive an email when new articles are posted on . The guideline was revised after two drugs received FDA approval for the treatment of lupus nephritis. The most ...

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, commented today on the 2024 Clinical Practice Guideline for the Evaluation and Management of ...

The final 2025 KDIGO Guideline suggests treatment with Nefecon should be considered in the majority of patients at risk of progressive loss of kidney function TARPEYO is a key product in Asahi Kasei’s ...

KDIGO has opened the draft guideline for public review through April 27, 2026, and is inviting feedback from clinicians, researchers, and stakeholders worldwide. For more information: ...

LONDON--(BUSINESS WIRE)--Ahead of the 61st European Renal Association (ERA) Congress, Medscape Education and KDIGO (Kidney Disease: Improving Global Outcomes) announce an educational collaboration ...

The board of the Immunonephrology Working Group of the European Renal Association reviewed 2 recent guidelines to establish if and how some of the differences may affect clinical practice. The ...

In the Phase III DUPLEX Study, Filspari reduced proteinuria by 46% and irbesartan by 30% over 108 weeks.

Credit: Getty Images KDIGO guidelines, while well-intentioned and supported by international experts, often fail to fully account for the specific needs of patients in the United States. Should ...

SAN DIEGO & ST. GALLEN, Switzerland--(BUSINESS WIRE)--CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice guidelines for the ...